Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules
Primary Purpose
Lung Neoplasms
Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
LungBrella marker implantation and VATS partial lobe resection
Sponsored by
About this trial
This is an interventional treatment trial for Lung Neoplasms focused on measuring lung neoplasm, localization of lung nodules, ground glass opacity
Eligibility Criteria
Inclusion Criteria:
Subjects should meet all of the following criteria
- diagnosis of pulmonary nodule, single nodule operation to be performed and nodule to be located by the decision of chief surgeon.
- commit to follow the research procedures and cooperate with the implementation of the whole process research
- 1 / 3 of pulmonary nodules are located in the periphery of the lung
- signed informed consent with date
Exclusion Criteria:
- the target lesion is close to the hilar or large blood vessels
- subjects with FEV1 less than 1.2 in lung function
- subjects with cardiac function III and cardiac function IV (NYHA, New York)
- subjects with uncontrollable acute pleura infection
- patients with previous history of thoracic surgery (thoracotomy), plural infection, and plural thickening and adhesion on the affected side
- Other factors that investigators disagree enrollment.
Sites / Locations
- RuijinhospitalRuijin Hospital, Shanghai Jiao Tong University School of Medicine
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Arm A
Arm Description
LungBrella marker implanted into a predetermined position in the lung assisted by JediVision software and successfully marked the pulmonary nodules which needs to undergo Video-assisted thoracoscopic surgery
Outcomes
Primary Outcome Measures
Positioning success rate
When the distance between the LungBrella marker and the Pulmonary nodule is less than 10mm, the marker position is successful. The success rate is the proportion of successful cases to all operation cases
Secondary Outcome Measures
Procedure time
Collect total procedure time for lung localization and surgical resection.
Complications
Procedure-related complications will be recorded.
Full Information
NCT ID
NCT04211051
First Posted
December 23, 2019
Last Updated
August 29, 2021
Sponsor
Ruijin Hospital
Collaborators
Shanghai Futuo Zhida Medical Technology Co., Ltd
1. Study Identification
Unique Protocol Identification Number
NCT04211051
Brief Title
Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules
Official Title
Safety and Feasibility of a Novel Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules
Study Type
Interventional
2. Study Status
Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
April 15, 2020 (Actual)
Primary Completion Date
October 21, 2020 (Actual)
Study Completion Date
October 21, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ruijin Hospital
Collaborators
Shanghai Futuo Zhida Medical Technology Co., Ltd
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
As the detection of small pulmonary nodules continuously grows, the intraoperative localization of small pulmonary nodules is in great demand. The intraoperative localization nowadays is usually done under local anesthesia before surgery. There is a certain rate of failure and complication. The result of our early animal experiments show that the pulmonary surgery marker system can deliver the intraoperative localization safely and precisely under anesthesia, and the average distance between the localization and the simulated lesion is less than 5mm during surgery. Therefore, the safety and feasibility of the system require further evaluation in patients
Detailed Description
This is a prospective, single-center clinical trial initiated by the investigator. LungBrella marker can be accurately implanted into a predetermined position in the lung assisted by JediVision software and successfully marked the pulmonary nodules which needs to undergo Video-assisted thoracoscopic surgery. The study is expected to enroll 10 patients. Finally, the effectiveness and safety of the method will be evaluated. This method not only can complete pulmonary nodule localization in the operating room without occupying the resources of radiology department, but also can let patients receive pulmonary nodule location after anesthesia. Thereby the risks during transportation are avoided and the suffering of patients is reduced.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lung Neoplasms
Keywords
lung neoplasm, localization of lung nodules, ground glass opacity
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Arm A
Arm Type
Experimental
Arm Description
LungBrella marker implanted into a predetermined position in the lung assisted by JediVision software and successfully marked the pulmonary nodules which needs to undergo Video-assisted thoracoscopic surgery
Intervention Type
Device
Intervention Name(s)
LungBrella marker implantation and VATS partial lobe resection
Intervention Description
The enrolled patients will receive a plain chest CT scan,then the data be loaded into JediVision software. The JediVision software can navigate the location of nodule and facilitate the implantation of LungBrella marker in the operating room after general anesthesia,then the patients will receive VATS partial lobe resection .
Primary Outcome Measure Information:
Title
Positioning success rate
Description
When the distance between the LungBrella marker and the Pulmonary nodule is less than 10mm, the marker position is successful. The success rate is the proportion of successful cases to all operation cases
Time Frame
Immediately after resection
Secondary Outcome Measure Information:
Title
Procedure time
Description
Collect total procedure time for lung localization and surgical resection.
Time Frame
Duration of procedure
Title
Complications
Description
Procedure-related complications will be recorded.
Time Frame
One month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects should meet all of the following criteria
diagnosis of pulmonary nodule, single nodule operation to be performed and nodule to be located by the decision of chief surgeon.
commit to follow the research procedures and cooperate with the implementation of the whole process research
1 / 3 of pulmonary nodules are located in the periphery of the lung
signed informed consent with date
Exclusion Criteria:
the target lesion is close to the hilar or large blood vessels
subjects with FEV1 less than 1.2 in lung function
subjects with cardiac function III and cardiac function IV (NYHA, New York)
subjects with uncontrollable acute pleura infection
patients with previous history of thoracic surgery (thoracotomy), plural infection, and plural thickening and adhesion on the affected side
Other factors that investigators disagree enrollment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hecheng Li, MD&PHD
Organizational Affiliation
Ruijin hospitalRuijin Hospital, Shanghai Jiao Tong University School of Medicine
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hecheng Li, MD&PHD
Organizational Affiliation
Ruijin Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
RuijinhospitalRuijin Hospital, Shanghai Jiao Tong University School of Medicine
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200025
Country
China
12. IPD Sharing Statement
Citations:
PubMed Identifier
35004246
Citation
Li C, Zheng Y, Yuan Y, Li H. Augmented reality navigation-guided pulmonary nodule localization in a canine model. Transl Lung Cancer Res. 2021 Nov;10(11):4152-4160. doi: 10.21037/tlcr-21-618.
Results Reference
derived
Learn more about this trial
Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules
We'll reach out to this number within 24 hrs